MENU
ANTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

AN2 Therapeutics (ANTX) Earnings Date & Reports

AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform... Show more

A.I. Advisor
published Earnings

ANTX is expected to report earnings to rise 50.00% to -31 cents per share on November 06

AN2 Therapeutics ANTX Stock Earnings Reports
Q3'25
Est.
$-0.31
Q2'25
Beat
by $0.10
Q1'25
Missed
by $0.10
Q4'24
Beat
by $0.02
Q3'24
Beat
by $0.02
The last earnings report on August 12 showed earnings per share of -20 cents, beating the estimate of -31 cents. With 52.87K shares outstanding, the current market capitalization sits at 29.24M.
View a ticker or compare two or three
ANTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ANTX showed earnings on August 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Managed Health Care
Address
1800 El Camino Real
Phone
+1 650 331-9090
Employees
41
Web
https://www.an2therapeutics.com